| The ornithine decarboxylase gene is a transcriptional target of c-Myc. C Bello-Fernandez, G Packham, JL Cleveland Proceedings of the National Academy of Sciences 90 (16), 7804-7808, 1993 | 1011 | 1993 |
| Chronic lymphocytic leukaemia TJ Kipps, FK Stevenson, CJ Wu, CM Croce, G Packham, WG Wierda, ... Nature reviews Disease primers 3 (1), 1-22, 2017 | 731 | 2017 |
| B-cell receptor signaling in chronic lymphocytic leukemia FK Stevenson, S Krysov, AJ Davies, AJ Steele, G Packham Blood, The Journal of the American Society of Hematology 118 (16), 4313-4320, 2011 | 502 | 2011 |
| High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27kip1 and degree of … S Fredersdorf, J Burns, AM Milne, G Packham, L Fallis, CE Gillett, ... Proceedings of the National Academy of Sciences 94 (12), 6380-6385, 1997 | 488 | 1997 |
| Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia S Lanham, T Hamblin, D Oscier, R Ibbotson, F Stevenson, G Packham Blood, The Journal of the American Society of Hematology 101 (3), 1087-1093, 2003 | 407 | 2003 |
| Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma T Armstrong, G Packham, LB Murphy, AC Bateman, JA Conti, DR Fine, ... Clinical cancer research 10 (21), 7427-7437, 2004 | 382 | 2004 |
| Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis G Packham, JL Cleveland Molecular and cellular biology, 1994 | 346 | 1994 |
| c-Myc and apoptosis G Packham, JL Cleveland Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1242 (1), 11-28, 1995 | 338 | 1995 |
| Mcl-1 J Michels, PWM Johnson, G Packham The international journal of biochemistry & cell biology 37 (2), 267-271, 2005 | 324 | 2005 |
| Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status C Ian Mockridge, KN Potter, I Wheatley, LA Neville, G Packham, ... Blood 109 (10), 4424-4431, 2007 | 303 | 2007 |
| Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia LS Young, R Lau, M Rowe, G Niedobitek, G Packham, F Shanahan, ... Journal of virology 65 (6), 2868-2874, 1991 | 287 | 1991 |
| Bodyguards and assassins: Bcl‐2 family proteins and apoptosis control in chronic lymphocytic leukaemia G Packham, FK Stevenson Immunology 114 (4), 441-449, 2005 | 249 | 2005 |
| Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma J Okosun, RL Wolfson, J Wang, S Araf, L Wilkins, BM Castellano, ... Nature genetics 48 (2), 183-188, 2016 | 240 | 2016 |
| E2F-1: DP-1 induces p53 and overrides survival factors to trigger apoptosis SW Hiebert, G Packham, DK Strom, R Haffner, M Oren, G Zambetti, ... Molecular and Cellular Biology 15 (12), 6864-6874, 1995 | 223 | 1995 |
| Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins V Coelho, S Krysov, AM Ghaemmaghami, M Emara, KN Potter, P Johnson, ... Proceedings of the National Academy of Sciences 107 (43), 18587-18592, 2010 | 217 | 2010 |
| Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation G PACKHAM, M BRIMMELL, LJ CLEVELAND Biochemical Journal 328 (3), 807-813, 1997 | 217 | 1997 |
| BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability M Brimmell, R Mendiola, J Mangion, G Packham Oncogene 16 (14), 1803-1812, 1998 | 215 | 1998 |
| Induction of cytosolic calcium flux by CD20 is dependent upon B Cell antigen receptor signaling CA Walshe, SA Beers, RR French, CHT Chan, PW Johnson, GK Packham, ... Journal of Biological Chemistry 283 (25), 16971-16984, 2008 | 213 | 2008 |
| BAG-1: a multifunctional regulator of cell growth and survival PA Townsend, RI Cutress, A Sharp, M Brimmell, G Packham Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1603 (2), 83-98, 2003 | 211 | 2003 |
| Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1 CM Eischen, G Packham, J Nip, BE Fee, SW Hiebert, GP Zambetti, ... Oncogene 20 (48), 6983-6993, 2001 | 211 | 2001 |
